In Good Health: Weight Loss Drugs And The Falling Obesity Rate

NPR

Published October 10, 2024 at 9:11 AM EDT

This picture shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy.

For the first time in decades, obesity rates in the U.S. are not on the rise.

The adult obesity rate fell to about 40 percent in 2023, down from 41.9 percent in 2020, according to the latest National Health and Nutrition Examination Survey from the CDC.

While the study doesn't pinpoint one sole reason for the change, the timing coincides with the rise of a new class of drugs targeting diabetes and weight loss, like Ozempic and Wegovy.

As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.

Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.

Recent Stories

WRVO runs on listener support.

WRVO is now well into its second year without federal funding. Through it all, our mission has stayed the same: serving central and upstate New York with trusted journalism, vital local coverage, and the diverse programming that informs and connects our communities. Listeners like you are what keep journalists on the ground, asking the hard questions that matter to our region.

Stand with public media and make your gift today. You'll be supporting more than yourself. You'll be supporting everyone who depends on WRVO as a trusted resource and civic cornerstone in central and upstate New York.

Support WRVO now